Join us at key events to close out 2026

Looking ahead to the end of 2026, Mabqi will be participating in several leading scientific conferences across Europe and the United States.
These events will be an opportunity to showcase our latest advances and to engage with partners, collaborators, and the broader biopharma community. 

📍 Where to meet us? 

•  Ion Channels – Targeted Drug Development Summit – Boston, USA | September 23–24 
  🎤 Johanna Marines will have the pleasure to give an oral presentation on “Targeting TRPV6 with monoclonal antibodies to enable selective ion channel modulation for anti-tumor activity in oncology”.

•  Festival of Biologics Europe – Basel, Switzerland | October 13–15 
  🎤 Johanna Marines will have the pleasure to share the latest results on MQI-181, a tumor-selective ADC in hemato-oncology during an oral presentation.
  You’ll also meet Anne Chevrel, Head of Discovery, and Cécile Durand, BD Director, on the Choose France Pavillon.

• BIO-Europe – Cologne, Germany | November 9–11
  🤝 Sylvain Yon, CEO, will be attending the congress and connect with industry leaders, explore new collaborations, and share our latest advances in antibody discovery.

• PEGS Europe – Lisbon, Portugal | November 16–19
  📌 Meet Anne Chevrel and Cecile Durand to discuss antibody discovery and next-generation biologics. 

Whether you’re interested in antibody discovery, research collaborations or partnering, we’d be delighted to connect. 

🔗 Let’s schedule a meeting: https://mabqi.com/contact/